Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Amitabh Bachchan Calls Son Abhishek His "True Inheritor" In Heartfelt Post

Amitabh Bachchan recently shared an emotional blog post dedicated to his son Abhishek Bachchan. He expressed his pride in his journey as an ...